Skip to main content

Table 12 Summary of outcome measures used according to ICS recommendations, need for surgery, side effects

From: Pelvic floor muscle training and adjunctive therapies for the treatment of stress urinary incontinence in women: a systematic review

Studies C1 C2 C3 C4 C5 % subjects proceeding to surgery No serious adverse events reported
Aksac (2003)   1 1 1    
Arvonen (2001) 1 1 1     
Balmforth (2004) 1 1   2    
Berghmans (1996) 1 2 1 1    
Bidmead (2002) 1 1   1    
Bo (1999) 3 3 1 1    yes
Bo (2000)     1    
Cammu & van Nylen (1998) 2 3 1 1   17 yes
Chen (1999)   2 1     yes
Dumoulin (1995) 1 1 1     
Dumoulin (2004) 1 1 1 2    yes
Finkenhagen (1998) 1       
Glavind (1996) 1 1      yes
Hay-Smith (2002) 1 2      
Johnson (2001) 1 2 1     
Knight (1998) 1 1 1     
Miller (1998)   1      
Morkved (2002) 2 2 1 1   4.3–6.3 yes
Pages (2001) 1   1     
Parkkinen (2004) 1 1 1    10.5 yes
Pieber (1995) 1      0  
Sung (2000) 1       
Turkan (2005) 1 3 1     
Wong (2001) 1 2 1 1    
  1. ICS Outcome Measurement categories; C 1= patient symptoms: perception of cure/improvement; C 2 = quantification of symptoms (objective measures): pad use, diary of incontinent episodes, pad tests; C 3 = clinicians' measures (pelvic floor muscle measures); C 4 = quality of life measures; C 5 = socioeconomic measures, blank cells indicate no relevant report.